China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A non-invasive biomarker model for dynamic monitoring and assessment of the risk of disease progression in Epstein-Barr virus (EBV)-related diseases'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129842
Registration Time: 2026/08/11
Type: Diagnostic test
Primary Sponsor: Huashan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337638
Published by HT Digital Content Services with permission from Health Daily Digest....